RxDoctor Payments Data

Samuel Reck, MD

Dermatology · Billings, MTNPI 1790832756

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $174, 8.5 times the $21 reported in 2020. That places this record below the midpoint for dermatology clinicians in MT, where the typical reported total is $1,595.

$332in general payments, 2019–2025

Across 18 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$47
  • Novartis$47
  • Incyte Corporation$38
  • AbbVie$38
  • Regeneron Healthcare Solutions, Inc.$28
  • E.r. Squibb & Sons, L.L.C.$26
  • plus $108 from 6 others

What the payments were for

  • Food & beverage$31294%
  • Education$216%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$332 in reported general payments places this provider in the 30th percentile of 46 dermatology providers in Montana.

See all dermatology providers in Montana

Medicare billing

Part B allowed, 2024
$221,051
Medicare patients
920
Services billed
7,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab11$99,431
Dupixent PenDupilumab15$55,858
Fluorouracil133$10,098
Clobetasol Propionate182$6,968
Betamethasone Dipropionate75$2,139
Mometasone Furoate69$1,485
Doxycycline Monohydrate46$1,448
Metronidazole26$1,255
Ketoconazole45$1,054
Doxycycline Hyclate30$1,039
Pentoxifylline19$800
Clindamycin Phosphate30$750
Triamcinolone Acetonide59$530
MethotrexateMethotrexate Sodium19$429
ValacyclovirValacyclovir Hcl13$323

Paid to pharmacies, not to this prescriber.

Other dermatology in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →